Asset Acquisitions and Disposals::STRIKING-OFF OF INDIRECT WHOLLY-OWNED SUBSIDIARY, DAC PHARMALAB PTE LTD

HYPHENS PHARMA INTERNATIONAL LIMITED

(Company Registration No. 201735688C)

(Incorporated in the Republic of Singapore)

STRIKING-OFF OF INDIRECT WHOLLY-OWNED SUBSIDIARY, DAC PHARMALAB

PTE LTD

The Board of Directors of Hyphens Pharma International Limited (the "Company", and together with its subsidiaries, the "Group") wishes to announce that DAC Pharmalab Pte Ltd ("DAC"), a wholly-owned subsidiary of Hyphens Pharma Pte. Ltd. which in turn is a wholly- owned subsidiary of the Company, has submitted an application to the Accounting and Corporate Regulatory Authority ("ACRA") Singapore on 9 December 2021 to strike its name off the Register of the Companies pursuant to Section 344A of the Companies Act, Chapter 50 of Singapore ("Strike-Off").

DAC is a dormant company. The Strike-Off is not expected to have any material impact on the net tangible assets and earnings per share of the Company for the current financial year ending 31 December 2021.

None of the directors or controlling shareholders or substantial shareholders of the Company has any interest, direct or indirect, in the Strike-Off, save for their interests arising by way of their shareholdings and/or directorships, as the case may be in the Company.

BY ORDER OF THE BOARD

Lim See Wah

Executive Chairman and Chief Executive Officer

Date: 9 December 2021

This announcement has been reviewed by the Sponsor, SAC Capital Private Limited. ("Sponsor").

This announcement has not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of this announcement including the accuracy, completeness or correctness of any information, statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms Lee Khai Yinn, who can be contacted at 1 Robinson Road, #21-00 AIA Tower, Singapore 048542, Telephone: [phone].